Kambiz Yazdi
Stock Analyst at BTIG
(4.27)
# 1,574
Out of 4,683 analysts
75
Total ratings
61%
Success rate
17.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintained: Buy | $65 | $49.07 | +32.46% | 9 | Aug 20, 2026 | |
| ABSI Absci | Maintained: Buy | $13 | $9.99 | +30.13% | 5 | Aug 11, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $6.25 | - | 9 | Aug 10, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $57 | $32.90 | +73.28% | 8 | Aug 6, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $24 | $12.13 | +97.86% | 6 | Aug 5, 2026 | |
| KZIA Kazia Therapeutics | Maintained: Buy | $34 | $14.07 | +141.65% | 3 | Jul 30, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $810 | $386.19 | +109.74% | 15 | Jun 29, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €82.10 | +47.38% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $31 | $26.46 | +17.16% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $75.33 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $20.75 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.30 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.28 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $14 | $0.4093 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0022 | n/a | 1 | May 31, 2023 |
Rapport Therapeutics
Aug 20, 2026
Maintained: Buy
Price Target: $65
Current: $49.07
Upside: +32.46%
Absci
Aug 11, 2026
Maintained: Buy
Price Target: $13
Current: $9.99
Upside: +30.13%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.25
Upside: -
vTv Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $57
Current: $32.90
Upside: +73.28%
Zevra Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $24
Current: $12.13
Upside: +97.86%
Kazia Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $34
Current: $14.07
Upside: +141.65%
Praxis Precision Medicines
Jun 29, 2026
Maintained: Buy
Price Target: $810
Current: $386.19
Upside: +109.74%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €82.10
Upside: +47.38%
Arcutis Biotherapeutics
Jan 15, 2026
Maintained: Buy
Price Target: $31
Current: $26.46
Upside: +17.16%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $75.33
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $20.75
Upside: n/a
Aug 28, 2024
Maintained: Buy
Price Target: $15
Current: $6.30
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.28
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $15 → $14
Current: $0.4093
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0022
Upside: n/a